Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study-Reference-Cited by-同舟云学术

Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study

Published:2013-09 Issue:9 Volume:98 Page:3599-3607
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Ganie Mohd Ashraf,Khurana Madan Lal,Nisar Sobia,Shah Parvaiz Ahmed,Shah Zaffar Amin,Kulshrestha Bindu,Gupta Nandita,Zargar Mohd Afzal,Wani Tariq Ahmed,Mudasir Syed,Mir Farooq Ahmed,Taing Shahnaz

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin-induced PCSK9 inhibition further decreases LDL-C following statin treatment in patients with coronary artery disease and without diabetes;Journal of Cardiovascular Pharmacology;2024-05-21

2. Management of Hypertension in Patients With Polycystic Ovarian Syndrome: A Mini-Review;Cardiology in Review;2024-02-02

3. Exploitation of mangliculous marine fungi, Amarenographium solium, for the green synthesis of silver nanoparticles and their activity against multiple drug-resistant bacteria;Open Chemistry;2024-01-01

4. Inter-relationship between polycystic ovary syndrome and metabolic syndrome;Metabolic Syndrome;2024

5. Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis;Medicine;2023-10-13